Furthermore, SNO-Drp1 levels were increased in a brain region (striatum) that displays neurotoxicity in the early stages of HD, suggesting that SNO-Drp1 initiates mitochondrial fragmentation and synaptic damage in the early stages of the disease. The gene discussed is DNM1L; the disease is Huntington disease.